A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL. 

Diabetes Technology & Therapeutics. 2024

Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications. 

Diabetes Technology & Therapeutics. 2024

Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. 

Diabetes care. 2024

Continuous glucose monitoring-derived differences in pregnancies with and without adverse perinatal outcomes. 

Obstetrics and Gynecology. 2024

Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. 

BMJ open diabetes research & care. 2024

A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes. 

Diabetes Technology & Therapeutics. 2023

Assessment of the glucose management indicator using different sampling durations. 

Diabetes Technology & Therapeutics. 2023

Comprehensive telehealth model to support diabetes self-management. 

JAMA network open. 2023

Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. 

Endocrine Reviews. 2023

The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring. 

Diabetes Technology & Therapeutics. 2023

A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G. 

Diabetes Technology & Therapeutics. 2022

Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems. 

Diabetes Technology & Therapeutics. 2022

The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial. 

Diabetes Technology & Therapeutics. 2022

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 

Lancet (London, England). 2021

Beyond A1C-standardization of continuous glucose monitoring reporting: why it is needed and how it continues to evolve. 

Diabetes Spectrum. 2021

Continuous glucose monitoring and glycemic control in patients with type 2 diabetes treated with basal insulin-reply. 

JAMA. 2021

Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 

JAMA. 2021

Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data. 

Diabetes, Obesity & Metabolism. 2021

Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives. 

Diabetes Technology & Therapeutics. 2021

Real-world, patient-reported and clinic data from individuals with type 1 diabetes using the MiniMed 670G hybrid closed-loop system. 

Diabetes Technology & Therapeutics. 2021

The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 

Diabetes care. 2021

Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 

Journal of the Endocrine Society. 2020

Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial. 

JAMA. 2020

Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 

JAMA. 2020

. 2018;41:2275-2280. 

Diabetes care. 2019

Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. 

Journal of Clinical Endocrinology and Metabolism. 2019

Emphasizing optimal diabetes management for all races/ethnicities, but not race/ethnicity-specific cut points for hemoglobin A1c. 

JAMA ophthalmology. 2019

State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. 

Diabetes Technology & Therapeutics. 2019

The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set. 

Diabetes Technology & Therapeutics. 2019

The relationships between time in range, hyperglycemia metrics, and HbA1c. 

Journal of Diabetes Science and Technology. 2019

Validation of time in range as an outcome measure for diabetes clinical trials. 

Diabetes care. 2019

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. 

Lancet (London, England). 2018

Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. 

Diabetes care. 2018

Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control. 

Diabetes Technology & Therapeutics. 2018

Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. 

Annals of Internal Medicine. 2017

Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND Randomized Clinical Trial. 

JAMA. 2017

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. 

The lancet. Diabetes & endocrinology. 2017

REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. 

Diabetes care. 2017

Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. 

Annals of Internal Medicine. 2017

The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. 

Diabetes care. 2017

Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. 

Pediatric Diabetes. 2016

Hypoglycemia in older adults with type 1 diabetes. 

Diabetes Technology & Therapeutics. 2016

Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. 

Diabetes care. 2016

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic registry. 

Diabetes care. 2015

Obesity in youth with type 1 diabetes in Germany, Austria, and the United States. 

Journal of Pediatrics. 2015

Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. 

Diabetes care. 2015

Depression in adults in the T1D Exchange Clinic Registry. 

Diabetes care. 2014

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. 

Diabetes care. 2014

Challenges and future directions of the T1D Exchange Clinic Network and registry. 

Journal of Diabetes Science and Technology. 2013

Comparison of autoantibody-positive and autoantibody-negative pediatric participants enrolled in the T1D Exchange clinic registry. 

Journal of Diabetes. 2013

Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry. 

Diabetes care. 2013

Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. 

Diabetes care. 2013

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). 

Diabetes Technology & Therapeutics. 2013

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. 

Journal of Diabetes Science and Technology. 2013

Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. 

Journal of Clinical Endocrinology and Metabolism. 2013

The T1D Exchange clinic registry. 

Journal of Clinical Endocrinology and Metabolism. 2012

The Glucose Management Indicator: time to change course [editorial]?. 

Diabetes care.  47. 2024

Continuous glucose monitoring for type 2 diabetes: how does it compare with type 1 diabetes [editorial]?. 

Diabetes Technology & Therapeutics.  24. 2022

Glucose management indicator (GMI): insights and validation using Guardian 3 and Navigator 2 sensor data [editorial]. 

Diabetes care.  42. 2019

Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels [editorial]. 

Annals of Internal Medicine.  168. 2018

Continuous glucose monitoring in patients with type 1 diabetes using insulin injections [editorial]. 

Diabetes care.  39. 2016

Hybrid closed-loop in adults with type 1 diabetes: impact of baseline A1c on glucose outcomes and insulin delivery [poster]

2019

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]. 

The lancet. Diabetes & endocrinology. 2023

Advances in technology for management of type 1 diabetes [review]. 

Lancet (London, England). 2019

Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]. 

Diabetes care. 2019

International consensus on use of continuous glucose monitoring [review]. 

Diabetes care. 2017

Cross-study comparisons done right: an illustration using two pivotal trials of closed-loop systems [abstract]. 

Diabetes. 2020

Factors associated with reduced hypoglycemia awareness (RHA) in older adults with type 1 diabetes (T1D) [abstract]. 

Diabetes. 2015

Hypoglycemia and glucose variability in older adults with type 1 diabetes (T1D) [abstract 408-P]. 

Diabetes. 2015